[1] GERTLER A A, COHEN H Y. SIRT6, a protein with many faces[J].Biogerontology, 2013,14(6):629-639. [2] MICHISHITA E, MCCORD R A, BERBER E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin[J]. Nature, 2008,452(7186):492-496. [3] KAWAHARA T L, MICHISHITA E, ADLER A S, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span[J]. Cell, 2009,136(1):62-74. [4] TANG Y L, ZHOU Y, WANG Y P, et al. SIRT6/NF-kappa B signaling axis in ginsenoside Rg1-delayed hematopoietic stem/progenitor cell senescence[J]. Int J Clin Exp Pathol, 2015,8(5):5591-5596. [5] KUGEL S, MOSTOSLAVSKY R. Chromatin and beyond:the multitasking roles for SIRT6[J]. Trends Biochem Sci, 2014,39(2):72-81. [6] ZHONG L, D'URSO A, TOIBER D, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1 alpha[J]. Cell, 2010,140(2):280-293. [7] CARDUS A, URYGA A K, WALTERS G, et al. SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence[J]. Cardiovasc Res, 2013,97(3):571-579. [8] KANFI Y, PESHTI V, GIL R, et al. SIRT6 protects against pathological damage caused by diet-induced obesity[J]. Aging Cell, 2010,9(2):162-173. [9] LIAO C Y, KENNEDY B K. Will the real aging Sirtuin please stand up?[J]. Cell Res, 2012,22(8):1215-1217. [10] SHUN C T, LIN S K, HONG C Y, et al. Sirtuin 6 modulates hypoxia-induced autophagy in nasal polyp fibroblasts via inhibition of glycolysis[J]. Am J Rhinol Allergy, 2016,30(3):179-185. [11] SEBASTIÁN C, ZWAANS B M, SILBERMAN D M, et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism[J]. Cell, 2012,151(6):1185-1199. [12] GARCIA-PETERSON L M, NDIAYE M A, Singh C K, et al. SIRT6 histone deacetylase functions as a potential oncogene in human melanoma[J]. Genes Cancer, 2017,8(9/10):701-712. [13] MING M, HAN W N, ZHAO B Z, et al. SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer[J]. Cancer Res, 2014,74(20):5925-5933. [14] LIU Y W, XIE Q R, WANG B S, et al. Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics[J]. Protein Cell, 2013,4(9):702-710. [15] LEE N, RYU H G, KWON J H, et al. SIRT6 depletion suppresses tumor growth by promoting cellular senescence induced by DNA damage in HCC[J]. PLoS One, 2016,11(11):e0165835. [16] RAN L K, CHEN Y, ZHANG Z Z, et al. SIRT6 overexpression potentiates apoptosis evasion in hepatocellular carcinoma via BCL2-associated X protein-dependent apoptotic pathway[J]. Clin Cancer Res, 2016,22(13):3372-3382. [17] MARQUARDT J U, FISCHER K, BAUS K, et al. Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients[J]. Hepatology, 2013,58(3):1054-1064. [18] HAN Z J, LIU L, LIU Y X, et al. Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer[J]. Int J Clin Exp Pathol, 2014,7(8):4774-4781. [19] ZHU B J, YAN Y J, SHAO B Y, et al. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer[J]. J Int Med Res, 2018,46(4):1517-1527. [20] CHEN T, SUN Z J, LIU F L, et al. RASSF1A and SIRT6 in non-small cell lung cancer:Relationship with clinical outcome[J]. Oncol Lett, 2017,14(5):5759-5764. [21] ZHOU J M, WU A, YU X T, et al. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway[J]. Oncol Rep, 2017,38(2):1059-1066. [22] FUKUDA T, WADA-HIRAIKE O, ODA K, et al. Putative tumor suppression function of SIRT6 in endometrial cancer[J]. FEBS Lett, 2015,589(17):2274-2281. [23] ZHANG J, YIN X J, XU C J, et al. The histone deacetylase SIRT6 inhibits ovarian cancer cell proliferation via down-regulation of Notch 3 expression[J]. Eur Rev Med Pharmacol Sci, 2015,19(5):818-824. |